Drug · DIN 02517841
VYNDAMAX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 15, 2021; first marketed September 15, 2021.
- Drug Identification Number (DIN)
- 02517841
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Tafamidis N07XX08
- Class
- Human
- Record last updated
- June 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TAFAMIDIS | 61 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 9, 2021: NOC 26239New Drug Submission (NDS)